WEBINAR ON STILL'S DISEASE: FROM PATHOGENESIS TO TARGETED THERAPY

• LUCA CANTARINI· PROF. ASSOCIATO REUMATOLOGIA UNIVERSITÀ DI SIENA

• LUCA CANTARINI· RELATORE
• EUGEN FEIST· RELATORE
• ROBERTO GIACOMELLI· RELATORE
• PIERO RUSCITTI· RELATORE
• ANTONIO VITALE· RELATORE

Ragione sociale

MCR CONFERENCE SRL

Stato accreditamento

STANDARD - 1° rinnovo

Di sistema

Still’s disease is a rare autoinflammatory disorder driven by dysregulation of innate immunity and excessive cytokine production, particularly interleukin-1. Despite advances in understanding its pathogenesis and the availability of targeted biologic therapies, the disease remains challenging due to its clinical heterogeneity, diagnostic delay, and potential for severe systemic complications. This webinar will provide an up-to-date overview of the pathogenetic mechanisms, diagnostic tools, and current therapeutic strategies for still’s disease. Experts will discuss recent eular/pres recommendations, current and emerging real-world evidence from the international aida network registry dedicated to still's disease, and evidence supporting early targeted intervention to improve outcomes and personalize patient management.

#2Linee guida - protocolli - procedure

Area: Obiettivi formativi tecnico-professionali

Partecipanti max

500

Verifica presenza

-

Verifica apprendimento

Questionario A Risposta Multipla (Se Online: Con Doppia Randomizzazione)